Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Brain Neoplasms × Trabectedin × Clear all

Sponsor

Conditions

Ovarian Neoplasms 6 Sarcoma 5 Liposarcoma 4 Leiomyosarcoma 3 Neoplasms 2 Fallopian Tube Neoplasms 2 Sarcoma, Ewing 1 Recurrent High Grade Meningioma 1 Recurrence 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasm Metastasis 1 Liposarcoma, Myxoid 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms 1

Interventions

Temozolomide 50 Bevacizumab 42 Radiotherapy 28 Radiosurgery 18 Carboplatin 14 Erlotinib Hydrochloride 10 Radiation 9 pembrolizumab 8 Vorinostat 8 Magnetic Resonance Spectroscopy 8 Irinotecan 8 Trastuzumab 7 Radiotherapy, Intensity-Modulated 7 Etoposide 7 Capecitabine 7 Lomustine 6 Lapatinib 6 dabrafenib 5 Sunitinib 5 Sorafenib 5 Ipilimumab 5 Imatinib Mesylate 5 Everolimus 5 Cyclophosphamide 5 cabozantinib 4 binimetinib 4 Therapeutics 4 Radiotherapy, Conformal 4 NVP-BKM120 4 Immunoglobulin G 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡